Advanced Search
Disease Phase
Title Drug
Clinical Trials Listing
  • < Previous
  • 1
  • Next >
  • Penn Treatment Trials (5)
  • Penn Non-Treatment Trials (6)
  • Phase 1: Solid Tumor Trials (3)
  • Proton Therapy Trials (2)
Active treatment trials at Penn's Abramson Cancer Center
Protocol ID Title Phase Modality Drug
NLG0405 A Phase III Study of Chemotherapy and Chemoradiotherapy With or Without HyperAcute®-Pancreas (Algenpantucel-L) Immunotherapy in Subjects With Surgically Resected Pancreatic Cancer III Chemotherapy, Radiotherapy, Immunotherapy gemcitabine; fluorouracil; HyperAcute Vaccine
UPCC 19211 A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer I / II Chemotherapy gemcitabine; nab-paclitaxel; hydroxychloroquine
UPCC 14211 Phase 1 Study of Preoperative Gemcitabine Plus CP-870,893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patient With Newly Diagnosed Resectable Pancreatic Carcinoma I Biological Therapy, Chemotherapy gemcitabine; CP-870,893
CA186-011 A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of BMS-663513 (Anti-CD137) in Subjects With Advanced and/or Metastatic Solid Tumors I Immunotherapy BMS-663513
UPCC 09211 A Feasibility and Registration Study of Proton Radiotherapy for Upper Gastrointestinal Malignancies Not Specified Radiotherapy, Proton Therapy Not Applicable
Displaying: 1 - 5 of 5 Results
  • < Previous
  • 1
  • Next >